Abstract
The disease caused by the SARS-CoV-2 virus is multi-organ and involves almost all organs and systems. Myalgias and arthralgias and, in particular, back pain are common symptoms of COVID-19 and can be observed both at the onset of the disease and in the postcovid period. The causes of muscle and joint damage include both systemic inflammation and direct viral injury. Traditionally, musculoskeletal pain is treated with non-steroidal anti-inflammatory drugs. However, using this drug class in patients with COVID-19 requires caution due to the presence of comorbid diseases and possible complications of viral infection. The review discusses clinical variants and pathophysiological mechanisms of joints and muscles damage in patients with COVID-19 and treatment tactics for patients with musculoskeletal pain.
Highlights
Заболевание, вызванное вирусом SARS-CoV-2, является мультиорганным и вовлекает практически все органы и системы
The disease caused by the SARS-CoV-2 virus is multi-organ and involves almost all organs and systems
Musculoskeletal pain is treated with non-steroidal anti-inflammatory drugs
Summary
Заболевание, вызванное вирусом SARS-CoV-2, является мультиорганным и вовлекает практически все органы и системы. Боли различной локализации (головная боль, боль в спине, миалгии, артралгии) могут наблюдаться как в остром периоде болезни, так и в постковидном периоде. Факторы риска развития скелетно-мышечной боли у пациентов, перенесших COVID-19, изучены крайне мало, однако имеются данные об ассоциации миалгии и артралгии с высоким индексом массы тела [1].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
